D Koya

Summary

Affiliation: Kanazawa Medical University
Country: Japan

Publications

  1. pmc Diabetic angiopathy and angiogenic defects
    Ling Xu
    Division of Diabetology and Endocrinology, Kanazawa Medical University, Uchinada, Ishikawa, 920 0293, Japan
    Fibrogenesis Tissue Repair 5:13. 2012
  2. ncbi request reprint Statin use in patients with diabetes and kidney disease: the Japanese experience
    Daisuke Koya
    Division of Diabetology and Endocrinology, Kanazawa Medical University, Japan
    J Atheroscler Thromb 20:407-24. 2013
  3. ncbi request reprint Sirtuins as possible drug targets in type 2 diabetes
    Munehiro Kitada
    Division of Diabetology and Endocrinology, Kanazawa Medical University, Kahoku gun, Ishikawa prefecture 920 0293, Japan
    Curr Drug Targets 14:622-36. 2013
  4. pmc Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors
    Megumi Kanasaki
    Division of Diabetes and Endocrinology, Kanazawa Medical University, Uchinada, Ishikawa, Japan
    Fibrogenesis Tissue Repair 4:25. 2011
  5. pmc Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial
    D Koya
    Kanazawa Medical University, Uchinadacho, Kahokugun, Ishikawa, Japan
    Diabetologia 52:2037-45. 2009
  6. ncbi request reprint SIRT1, a calorie restriction mimetic, in a new therapeutic approach for type 2 diabetes mellitus and diabetic vascular complications
    Shinji Kume
    Department of Medicine, Shiga University of Medical Science, Otsu, Japan
    Endocr Metab Immune Disord Drug Targets 10:16-24. 2010

Collaborators

Detail Information

Publications6

  1. pmc Diabetic angiopathy and angiogenic defects
    Ling Xu
    Division of Diabetology and Endocrinology, Kanazawa Medical University, Uchinada, Ishikawa, 920 0293, Japan
    Fibrogenesis Tissue Repair 5:13. 2012
    ..Additionally, we discuss glucose metabolism defects that are associated with abnormal angiogenesis in atypical diabetic complications such as cancer...
  2. ncbi request reprint Statin use in patients with diabetes and kidney disease: the Japanese experience
    Daisuke Koya
    Division of Diabetology and Endocrinology, Kanazawa Medical University, Japan
    J Atheroscler Thromb 20:407-24. 2013
    ..This review summarizes evidence from studies in Western and Japanese populations to highlight the CV and renal benefits of lipid-lowering agents in CKD patients, including those with diabetes...
  3. ncbi request reprint Sirtuins as possible drug targets in type 2 diabetes
    Munehiro Kitada
    Division of Diabetology and Endocrinology, Kanazawa Medical University, Kahoku gun, Ishikawa prefecture 920 0293, Japan
    Curr Drug Targets 14:622-36. 2013
    ..In this review, we summarize the current understanding of the biological functions of SIRT1, SIRT3 and SIRT6 in metabolism and discuss their potential role as therapeutic targets in T2DM...
  4. pmc Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors
    Megumi Kanasaki
    Division of Diabetes and Endocrinology, Kanazawa Medical University, Uchinada, Ishikawa, Japan
    Fibrogenesis Tissue Repair 4:25. 2011
    ....
  5. pmc Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial
    D Koya
    Kanazawa Medical University, Uchinadacho, Kahokugun, Ishikawa, Japan
    Diabetologia 52:2037-45. 2009
    ..There is currently insufficient evidence to recommend a low-protein diet for type 2 diabetic patients with diabetic nephropathy. We assessed whether a low-protein diet could prevent the progression of diabetic nephropathy...
  6. ncbi request reprint SIRT1, a calorie restriction mimetic, in a new therapeutic approach for type 2 diabetes mellitus and diabetic vascular complications
    Shinji Kume
    Department of Medicine, Shiga University of Medical Science, Otsu, Japan
    Endocr Metab Immune Disord Drug Targets 10:16-24. 2010
    ..This review summarizes current understanding of the biological functions of SIRT1, and discusses its potential as a pharmacological target for fighting metabolic and vascular diseases...